Condition
SCC - Squamous Cell Carcinoma clinical trials and research
As of November 12, 2026, Find a Trial lists 7 SCC - Squamous Cell Carcinoma clinical trials that are recruiting, at sites in 3 countries (most in United States (6), France (1), Switzerland (1)). By phase: Phase 1 (4), Early Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 7Clinical trials
- 3Countries
Newest SCC - Squamous Cell Carcinoma clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Intratumoral fluorescent nivolumab before surgery in head and neck cancer | Early Phase 1 | Nashville, Tennessee | Recruiting | Aug 3, 2026 |
| Using [18F]NOTA-ABY030 PET/CT to clarify indeterminate head and neck squamous cell carcinoma lesions | Phase 1 | Nashville, Tennessee | Recruiting | Oct 15, 2025 |
| High-resolution PET-CT to visualize surgical tumor margins | — | Nashville, Tennessee | Recruiting | Apr 8, 2025 |
| Using a fluorescently labeled drug to improve surgery for head and neck cancer | Phase 1 | Nashville, Tennessee | Recruiting | Feb 11, 2025 |
| Injecting a viral particle to treat head and neck cancer | Phase 1 | Stanford, California | Recruiting | Dec 16, 2024 |
| Measuring circulating tumor DNA in patients with advanced upper aero-digestive tract cancer after radiotherapy | — | Caen, Caen and 6 other locations | Recruiting | Jun 27, 2024 |
| MQ710 with or without pembrolizumab for advanced skin and other solid tumors | Phase 1 | Basking Ridge, New Jersey and 6 other locations | Recruiting | May 15, 2023 |
All recruiting trials (7)
-
Intratumoral fluorescent nivolumab before surgery in head and neck cancer
This study tests injecting fluorescently labeled nivolumab directly into head and neck tumors to see if it is safe and whether it reaches nearby lymph nodes before surgical removal.
-
Using [18F]NOTA-ABY030 PET/CT to clarify indeterminate head and neck squamous cell carcinoma lesions
This trial will test whether the new PET imaging agent [18F]NOTA-ABY030 is safe and can better detect unclear primary or metastatic lesions in adults with head and neck squamous cell carcinoma.
-
High-resolution PET-CT to visualize surgical tumor margins
This will test whether a low-dose, high-resolution PET-CT scan of removed tumor tissue can help surgeons spot at-risk margins during surgery for adults with solid cancers such as head and neck squamous cell carcinoma.
-
Using a fluorescently labeled drug to improve surgery for head and neck cancer
This study is testing a special version of a cancer drug to see if it can help doctors see tumors better during surgery for patients with head and neck cancer.
-
Injecting a viral particle to treat head and neck cancer
This study is testing a new virus injection to see if it can help treat head and neck cancer in different groups of patients.
-
Measuring circulating tumor DNA in patients with advanced upper aero-digestive tract cancer after radiotherapy
This study is testing if measuring tumor DNA in the blood after radiation treatment can help predict how well patients with advanced throat and mouth cancer will do in the future.
-
MQ710 with or without pembrolizumab for advanced skin and other solid tumors
This will test different doses of MQ710, alone or together with pembrolizumab, in adults with advanced or recurrent solid tumors (including skin cancers) to find a safe dose with mild side effects.
Related topics
Quick answers
How many SCC - Squamous Cell Carcinoma clinical trials are recruiting right now?
7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in United States (6 trials), France (1 trial), Switzerland (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 4, Early Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.